ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
Orphazyme AS

Orphazyme AS (ORPH)

0.87
0.00
(0.00%)
마감 01 11월 5:00AM
0.00
0.00
(0.00%)
시간외 거래: -

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

주요 통계 및 세부정보

가격
0.87
매수가
0.85
매도가
0.865
거래량
-
0.00 일간 변동폭 0.00
0.00 52주 범위 0.00
전일 종가
0.87
개장가
-
최근 거래 시간
마지막 거래 시간
평균 볼륨(3m)
-
재정 규모
-
VWAP
-

ORPH 최신 뉴스

CytRx Highlights Orphazyme’s Published Results From Its Phase 2/3 Trial of Arimoclomol in Niemann-Pick Disease Type C

12-Month Study of Arimoclomol Showed a Clinically Meaningful Treatment Effect, Corresponding to a Reduction in Disease Progression Highlights Arimoclomol is Under Regulatory Review in Europe...

AIM ImmunoTech Announces Phase 2a Human Challenge Trial to Test its Drug Ampligen as an Intranasal Antiviral Prophylactic The...

OCALA, Fla., July 09, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that it has signed a contract to sponsor a Phase 2a Human Challenge Trial (HCT) to test...

Open Orphan plc Announces £3m COVID-19 Challenge Virus Manufacturing Contract

hVIVO to develop challenge agent based on new COVID-19 variants Open Orphan plc (AIM: ORPH), a rapidly growing specialist pharmaceutical services contract research organisation (CRO) and world...

CytRx Notes Orphazyme’s Announcement of Topline Results from Trial for Arimoclomol in the Treatment of Inclusion Body Myosi...

CytRx Corporation (OTCQB: CYTR) ("CytRx"), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, today noted that...

Ethics Approval Granted for Open Orphan’s COVID-19 Human Challenge Study Model

Call for volunteers to enroll in studies that will play a key part in developing effective vaccines and treatments for COVID-19 Open Orphan plc (AIM: ORPH), a rapidly growing specialist...

CytRx Issues Statement Regarding U.S. Regulatory Review of Arimoclomol for Niemann-Pick Disease Type C

CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories...

CytRx Announces Orphazyme’s U.S. Expansion Ahead of Potential Regulatory Approval of Arimoclomol for Niemann-Pick Disease T...

Highlights Orphazyme’s Establishment of U.S. Headquarters in Chicago and Recruitment of More Than 30 U.S. Employees Comments That Orphazyme’s Investments in the U.S. are Intended to Support...

CytRx Announces Orphazyme’s U.S. Expansion Ahead of Potential Regulatory Approval of Arimoclomol for Niemann-Pick Disease T...

Highlights Orphazyme’s Establishment of U.S. Headquarters in Chicago and Recruitment of More Than 30 U.S. Employees Comments That Orphazyme’s Investments in the U.S. are Intended to Support...

Orphan Medical Stockholders Approve Acquisition by Jazz Pharmaceuticals, Inc.

Orphan Medical, Inc. (NASDAQ:ORPH) announced that its stockholders, voting at a special meeting held this morning, have approved the proposed acquisition of the Company by Jazz Pharmaceuticals...

Orphan Medical Sees Lead Product Growing to $20 Million This Year

Orphan Medical Sees Lead Product Growing to $20 Million This Year MINNEAPOLIS, Feb. 23 /PRNewswire-FirstCall/ -- Orphan Medical, Inc.'s (NASDAQ:ORPH) chief executive officer John Bullion believes...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
STECSantech Holdings Limited
US$ 1.73
(103.53%)
42.61M
ROOTRoot Inc
US$ 68.40
(68.93%)
13.47M
HPAIHelport AI Ltd
US$ 6.08
(42.39%)
286.46k
AMIXAutonomix Medical Inc
US$ 14.5799
(42.38%)
8.4M
PLBYPLBY Group Inc
US$ 1.17
(41.24%)
138.81M
MDJHMDJM Ltd
US$ 0.2451
(-59.32%)
6.98M
EQEquillium Inc
US$ 0.859219
(-37.74%)
1.71M
ICCTiCoreConnect Inc
US$ 0.1521
(-37.41%)
1.08M
ELABElevai Labs Inc
US$ 0.0591
(-36.38%)
54.26M
VCNXVaccinex Inc
US$ 2.76
(-31.51%)
454.16k
NVDANVIDIA Corporation
US$ 132.76
(-4.72%)
267.41M
LUXHLuxUrban Hotels Inc
US$ 0.0404
(13.80%)
225.88M
SQQQProShares UltraPro Short QQQ
US$ 7.60
(7.65%)
210.49M
PLBYPLBY Group Inc
US$ 1.17
(41.24%)
138.34M
BFRIBiofrontera Inc
US$ 1.2203
(30.67%)
132.84M
amod1222333 amod1222333 5 분 전
lol do you people ever live in reality. This is done.
WSRC
oldstocks oldstocks 7 분 전
PB you have explained the OneMind, Dell, Nvidia partnership/connection so well, nobody else has been able to get that point across.
Sure I have, TJ has and others have tried to get that point across but people are letting that sink in and shows with the volume of interest.

http
AFFU
236T568 236T568 9 분 전
You need to read the thread. The October surprise.

https://x.com/allenanalysis/status/1852206076629745756
amod1222333 amod1222333 10 분 전
and you were entitled to lose 99% of your money. Well done!
ALPP
mick mick 11 분 전
#2 RARE PREMIUM---Super Rare Top 50 Wheat Pennies and Jefferson NICKEL's Coins in history -Coins Worth money! 1924 PLAIN

PENNY---1924- NO MINT MARK, PROFILE, ERRORS, DIE CRACKS, CONDITION, RARE, POPULATION, DOUBLE DIE, RARE, HIGH GRADE,
THIS 1924 FAIR CONDITION, 10-K OR MORE.
Wolf-man jack Wolf-man jack 17 분 전
WQLF ASKS; Is Daiwa Pharmaceutical interested in partnering with CV Sciences Lunar Fox 🦊 Wholly Owned Subsidiary? Have Mercy Have Faith Have Patience Have International Partners Have International M&A’s WQLF Ahooooooo

DAIWA PHARMACEUTICAL CO.,LTD.
F29
DAIWA PHAR
CVSI
lakers17 lakers17 18 분 전
Maybe the OTC is not for you. I'll keep playing the OTC. Made 7 figures in the OTC early 2021 (including lots on NSAV at .10+ bought in the trips) like many did and have played them for 30+ years. I literally own 150+ OTCs. The big winners covers the many losers we all have, like NSAV, a LOSER.
NSAV
nowwhat2 nowwhat2 23 분 전
re: DLE

https://investorshub.advfn.com/uimage/uploads/2024/11/1/reogfdle_voodoo.jpg
IBATF
236T568 236T568 23 분 전
Don't mess with JLo

https://x.com/Acyn/status/1852203248184152115
Bubae Bubae 23 분 전
No doubt that we will see much more debt with the Q3 filing in a few weeks. Meanwhile familiarize yourself with what Shawn Leon refers to as "perpetual financing" and the destructive powers of a regulation "A" offering on shareholders.


Bubae
Re: None
Friday, Octo
GRST
236T568 236T568 27 분 전
Can you imagine saying this a few days before the election? - A complete meltdown for the orangeone

https://x.com/atrupar/status/1852209432878342308
mick mick 27 분 전
RARE PREMIUM---Super Rare Top 50 Wheat Pennies and Jefferson NICKEL's Coins in history -Coins Worth money! 1924 PLAIN

PENNY---1924- NO MINT MARK, PROFILE, ERRORS, DIE CRACKS, CONDITION, RARE, POPULATION, DOUBLE DIE, RARE, HIGH GRADE,
THIS 1924 FAIR CONDITION, 10-K OR MORE.
jazz5201 jazz5201 29 분 전
Like i was saying, the naysayers are in major panic mode.........

Don't let your shares be stolen.........

There going to be worth millions..........

$$$$$$$$$$$$$$$$$$$
SPZI
BeachBum BeachBum 29 분 전
Structure unchanged 10-31
https://www.otcmarkets.com/stock/YUKA/security
YUKA
Bob Mullet Bob Mullet 39 분 전
Exactly, SCAMSIE! Watch how triggering "Exponential FLATLINING OF SHAREPRICE" makes some. It's beyond laughable the lengths some will go to discredit KBLBs stagnation, SOON, and its boiler room cheerleading crew. Sounds eerily familiar to the times we're facing now. Pathetic price, delusional outloo
KBLB
Wolf-man jack Wolf-man jack 41 분 전
WQLF SAYS: Curiosity killed the Kat but the WQLFPACK lives on YQU Understand. Why did CV Sciences list Daiwa Pharmaceutical From Japan on their LinkedIn page one month ago? Have Mercy Have Faith Have Patience Have International Partners Have International M&A’s WQLF Ahooooooo

https:/
CVSI
Bob Mullet Bob Mullet 42 분 전
Long and Kongs

Are holdin for a foldin!!
KBLB
molee molee 43 분 전
Nothing "bad" needs to happen right away ...

" Nasdaq’s notice has no immediate effect on the listing of the Company’s Class B common stock on the Nasdaq Capital Market. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial compliance period of 180 ca
RR
Bob Mullet Bob Mullet 43 분 전
Hey 👋🏻 now.

It’s the end of another week

Super long and big kong

Another week??!?
KBLB
norisknorewards norisknorewards 44 분 전
But, since this would be mind blowing to you.

Guess this is huge for dc vax?
NWBO
lakers17 lakers17 45 분 전
Maybe you need to consult AI more. That sure was helpful with NSAV. 🤣 Maybe the so called "bashers" are actually more OTC savvy. I was bullish on NSAV through 2021 and some time after. Then I became bearish for good reason. I know how to DD most OTCs with 30 years of experience. Yet,
NSAV
norisknorewards norisknorewards 47 분 전
Nah, actually 100% true. Was discussed (the scene on the show called 'industry') in great detail here on this board not too long ago.

Bad memory, eh shorty?
NWBO
leverage102 leverage102 1 시간 전
Does what work ? Is it a Technology ?
ERHE
1hunglo 1hunglo 1 시간 전
RDGL was 0.18 on Oct.10 to current pps 0.124….
RDGL

최근 히스토리

Delayed Upgrade Clock